Gastric perception thresholds are low and sensory neuropeptide levels high in Helicobacter pylori-positive functional dyspepsia

Digestion

Volumn 71, Issue 2, 2005, Pages 111-123

  Mönnikes, Hubert ^a,c   Van Der Voort, Ivo R ^a   Wollenberg, Birgit ^b   Heymann Mönnikes, Ingeborg ^a   Tebbe, Johannes J ^b   Alt, Wibke ^b   Arnold, Rudolf ^b   Klapp, Burghard F ^a   Wiedenmann, Bertram ^a   McGregor, Gerard P ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Calcitonin gene related peptide; Gastric distension; Hypersensitivity; Inflammation; Substance P

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NEUROPEPTIDE; SUBSTANCE P;

ADULT; ARTICLE; BACTERIAL INFECTION; BALLOON; BLOOD LEVEL; CHRONIC INFLAMMATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPEPSIA; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; HYPERSENSITIVITY; MALE; PAIN THRESHOLD; PATHOGENESIS; PATHOPHYSIOLOGY; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH DISTENSION; STOMACH MUCOSA;

ADOLESCENT; ADULT; CALCITONIN GENE-RELATED PEPTIDE; CASE-CONTROL STUDIES; DYSPEPSIA; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PAIN MEASUREMENT; PERCEPTION; STOMACH; SUBSTANCE P;

EID: 21044455440     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084625     Document Type: Article

References (55)

1. Holtmann G, Goebell H, Talley JN: Dyspepsia in consulters and non-consulters: Prevalence, healthcare seeking behavior and risk factors. Eur J Hepatol 1994;6:917-924.
2. Holtmann G, Talley JN, Goebell H: Association between H. pylori, duodenal mechanosensory thresholds and small intestinal motility in chronic unexplained dyspepsia. Dig Dis Sci 1996;41:1285-1291.
3. Mayer EA, Gebhart GF: Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994;107:271-293.
4. Collins SM: The immunomodulation of enteric neuromuscular function: Implications for motility and inflammatory disorders. Gastroenterology 1996;111:1683-1699.
5. De Giorgio R, Barbara G, Blennerhassett P, Wang L, Stanghellini V, Corinaldesi R, Collins SM, Tongas G: Intestinal inflammation and activation of sensory nerve pathways: A functional and morphological study in the nematode infected rat. Gut 2001;49:822-827.
6. Thumshirn M, Camilleri M, Saslow SB, Williams DE, Burton DD, Hanson RB: Gastric accommodation in non-ulcer dyspepsia and the role of Helicobacter pylori infection and vagal function. Gut 1999;44:55-64.
7. Mearin F, De Ribot X, Balboa A, Salas A, Varas MJ, Cucala M, Bartolomé R, Armengol JR, Malagelada J-R: Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia? Gut 1995;37:47-51.
8. Stanghellini V, Barbara G, de Giorgio R, Tosetti C, Cogliandro R, Cogliandro L, Salvioli B, Corinaldesi R: Review article: Helicobacter pylori, mucosal inflammation and symptom perception - New insights into an old hypothesis. Aliment Pharmacol Ther 2001;15:28-32.
9. Van Assche G, Barbara G, Deng Y, Lovato P, Gauldie J, Collins SM: Neurotransmitters modulate cytokine-stimulated interleukin 6 secretion in rat intestinal smooth muscle cells. Gastroenterology 1999;166:346-353.
10. Kuraishi Y, Nanayama T, Ohno H, Fujii N, Otaka A, Yajima H, Satoh M: Calcitonin gene-related peptide increases in the dorsal root ganglia of adjuvant arthritic rat. Peptides 1989;10: 447-452.
11. Fischer A, McGregor GP, Saria A, Philippin B, Kummer W: Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest 1996;98:2284-2291.
12. McMahon SB: NGF as a mediator of inflammatory pain. Philos Trans R Soc Lond B Biol Sci 1996;351:431-440.
13. Buéno L, Fioramonti J, Delvaux M, Frexinos J: Mediators and pharmacology of visceral sensitivity: From basic to clinical investigations. Gastroenterology 1997;122:1714-1743.
14. Holzer P: Calcitonin gene-related peptide; in Walsh JH, Dockray GJ (eds): Gut Peptides: Biochemistry and Physiology. New York, Raven Press, 1994, pp 493-523.
15. Otsuka M, Yoshioka K: Neurotransmitter functions of mammalian tachykinins. Physiol Rev 1993;73:229-308.
16. Holzer P: Local microcirculatory reflexes and afferent signaling in response to gastric acid challenge. Gut 2000;47(suppl 4):iv46-iv48; discussion iv52.
17. Spiller RC: Role of nerves in enteric infection. Gut 2002;51:759-762.
18. Sternini C, Anderson K: Calcitonin gene-related peptide-containing neurons supplying the rat digestive system: Differential distribution and expression pattern. Somatosens Mot Res 1992;9:45-59.
19. Vongthavaravat V, Mesiya S, Saymeh L, Xia Y, Harty RF: Mechanisms of transforming growth factor-alpha (TGF-alpha) induced gastroprotection against ethanol in the rat: Roles of sensory neurons, sensory neuropeptides, and prostaglandins. Dig Dis Sci 2003;48:329-333.
20. Holzer P, Holzer-Petsche U: Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol Ther 1997;73:219-263.
21. Julia V, Morteau O, Buéno L: Involvement of neurokinin 1 and 2 receptors in viscerosensitive response to rectal distension in rats. Gastroenterology 1994;107:94-102.
22. Maggi CA: Tachykinin as peripheral modulators of primary afferent nerves and visceral sensitivity. Pharmacol Res 1997;36:153-169.
23. Kishimoto S, Kobayash H, Machine H, et al: High concentrations of substance P as a possible transmission of abdominal pain in rats with chemical induced ulcerative colitis. Biomed Res 1994;15:133-140.
24. Talley NJ, Stanghellini V, Heading RS, Koch KL, Malagelada JR, Tytgat G: Functional gastroduodenal disorders. Gut 1999;46(suppl 2): II37-II42.
25. Dixon MF, Genta RM, Yardley JH, et al: Classification and grading of gastritis. The updated Sydney System. International Workshop on Histopathology of Gastritis, Houston, 1994. Am J Surg Pathol 1996;20:1161-1181.
26. Lembo T, Munakata J, Naliboff B, Fullerton S, Mayer EA: Sigmoid afferent mechanisms in patients with irritable bowel syndrome. Dig Dis Sci 1997;42:1112-1120.
27. Gracely RH, Kwilosz DM: The Descriptor Differential Scale: Applying psychophysical principles to clinical pain assessment. Pain 1988; 35:279-288.
28. McGregor GP, Bloom SR: Radioimmunoassay of substance P and its stability in tissue. Life Sci 1983;32:655-662.
29. McGregor GP, Conlon JM: Regulatory peptide and serotonin content and brush-border enzyme activity in the rat gastrointestinal tract following neonatal treatment with capsaicin: Lack of effect on epithelial markers. Regul Pept 1991;32:109-120.
30. Cheli R, Perasso A, Giacosa A: Dyspepsia and chronic gastritis. Hepatogastroenterology 1983;30:21-23.
31. Mertz H, Fullerton S, Naliboff B, Mayer EA: Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998;2: 814-822.
32. Lémann M, Dederding JP, Flourié B, Franchisseur C, Rambaud JC, Jian R: Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci 1991; 36:1249-1254.
33. Saslow SB, Thumshirn M, Camilleri M, Locke GR III, Thomforde GM, Burton DD, Hanson RB: Influence of H. pylori infection on gastric motor and sensory function in asymptomatic volunteers. Dig Dis Sci 1998;43:258-264.
34. Braden B, Caspary WF, Lembcke B: Density of gastric Helicobacter pylori colonization is not associated with occurrence of dyspeptic symptoms. Dig Dis Sci 1997;42:2120-2123.
35. Buckley MJ, O'Shea J, Grace A, English L, Keane C, Hourihan D, O'Morain CA: A community-based study of the epidemiology of Helicobacter pylori infection and associated asymptomatic gastroduodenal pathology. Eur J Gastroenterol Hepatol 1998;10:375-379.
36. Glasbrenner B, Weiler S, Ellenrieder V, Muller P, Adler G: Relationship between Helicobacter pylori infection, histological gastritis and functional dyspepsia. Hepatogastroenterology 1998;45:2238-2243.
37. Pereira-Lima JG, Scholl J, Pinheiro JB, Pereira-Lima L, Riemann JF: Helicobacter pylori-associated gastritis: Does it play a role in functional dyspepsia? Z Gastroenterol 1995;33: 421-425.
38. Talley NJ: A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994;106:1174-1183.
39. Armstrong D: Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol 1996;31:38-47.
40. Klatt S, Pieramico O, Guethner C, Glasbrenner B, Beck K, Adler G: Gastric hypersensitivity in nonulcer dyspepsia. An inconsistent finding. Dig Dis Sci 1997;42:720-723.
41. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J: Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001;121:526-535.
42. Holtmann G, Gschossmann J, Buenger L, Gerken G, Talley NJ: Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin? Gastroenterology 2002;123:1451-1458.
43. Bercik P, De Giorgio R, Blennerhassett P, Verdu EF, Barbara G, Collins SM: Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection. Gastroenterology 2002;123:1205-1215.
44. Troncon LE, Thompson DG, Ahluwalia NK, Barlow J, Heggie L: Relations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy. Gut 1995;37: 17-22.
45. Lopez GAR, Lopez de LGA, Andrush A: Comparison between gastric and esophageal mechanosensitivity in patients with functional dyspepsia. Acta Gastroenterol Latinoam 1996;26: 143-147.
46. Salet GAM, Samsom M, Roelofs JMM, van Berge Henegouwen GP, Smout AJPM, Akkermans LMA: Responses to gastric distension in functional dyspepsia. Gut 1998;42:823-829.
47. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998;115:1346-1352.
48. Smith VC, Dhatt N, Buchan AM: The innervation of the human antro-pyloric region: Organization and composition. Can J Physiol Pharmacol 2001;79:905-918.
49. Kaneko H, Mitsuma T, Uchida K, Furusawa A, Morise K: Immunoreactive somatostatin, substance P, and calcitonin gene-related peptide concentrations of the human gastric mucosa in patients with nonulcer dyspepsia and peptic ulcer disease. Am J Gastroenterol 1993;88: 898-904.
50. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, Wilson I: Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122:1778-1783.
51. Wallace JL, McKnight W, Wilson TL, Del Soldato P, Cirino G: Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: Role of neutrophils. Am J Physiol 1997;273:G1246-G1251.
52. Holzer P, Livingston EH, Guth PH: Sensory neurons signal for an increase in rat gastric mucosal blood flow in the face of pending acid injury. Gastroenterology 1991;101:416-423.
53. Holzer P: Implications of tachykinins and calcitonin gene-related peptide in inflammatory bowel disease. Digestion 1998;59:369-383.
54. Chovet M: Gastrointestinal functional bowel disorders: New therapies. Curr Opin Chem Biol 2000;4:428-432.
55. McLean PG, Picard C, Garcia-Villar R, More J, Fioramonti J, Bueno L: Effects of nematode infection on sensitivity to intestinal distension: Role of tachykinin NK2 receptors. Eur J Pharmacol 1997;337:279-282.